RUNX3 and lung cancer: The results of immunostaining showed that Arf was not expressed in KPRL/F-TAM(-) lung cancers, whereas it was expressed in KPRL/F-TAM(+) lung cancers in which Runx3 was restored (Supplementary Figure S8A).